You are here: Industry Insights > Drug

News List

First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA drugs
May 22, 2019
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA.
Civica Rx and Xellia Join Forces to Reduce Chronic Drug Shortages contractpharma
May 17, 2019
Xellia becomes Civica’s first supplier partner and will produce essential antibiotics in short supply in U.S. hospitals.
Creating a modern landscape europeanpharmaceuticalreview
May 17, 2019
There are many business challenges to developing a biologics drug, one of which is effective data management.
Connecticut AG Leads Coalition in Antitrust Lawsuit against 20 Generic Drug Manufacturers in Price Fix Conspiracy americanpharmaceuticalreview
May 16, 2019
Connecticut Attorney General William Tong has led a 44-state coalition in announcing a lawsuit against Teva Pharmaceuticals and ...
Celgene’s Pomalyst secures breakthrough designation pharmaceutical-technology
May 16, 2019
The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to Celgene’s Pomalyst (pomalidomide) in HIV-positive and HIV-negative Kaposi sarcoma.
BioDuro Continues Expansion with Leadership Appointments contractpharma
May 16, 2019
Key hires to support scientific excellence, operational and financial growth plans and global business development.
Novartis Buys Dry Eye Drug from Takeda for $5.3B contractpharma
May 16, 2019
Takeda also divests TachoSil to Ethicon for $400 million.
IntelGenx Appoints André Godin as President contractpharma
May 16, 2019
Will retain current role as chief financial officer.
Stroke drug cocktail normalizes brain fluids, restores movement in mice fiercebiotech
May 15, 2019
Adrenergic receptor (AdR) antagonists work by counteracting electrical and chemical disturbances in the brain.
Collaboration to produce new clinical stage TB drug candidates europeanpharmaceuticalreview
May 15, 2019
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page